# Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

> **NCT04262167** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 24 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease

## Interventions

- **BIOLOGICAL:** Lung Spheroid Stem Cells 100 million
- **BIOLOGICAL:** Lung Spheroid Stem Cells 200 million

## Key facts

- **NCT ID:** NCT04262167
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-22
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04262167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04262167, "Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04262167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*